<DOC>
	<DOCNO>NCT01088685</DOCNO>
	<brief_summary>Study evaluate safety performance new blister patch intend treat blister heel foot .</brief_summary>
	<brief_title>Hydrogel Blister Patch Prototype Treatment Foot Blisters Heel</brief_title>
	<detailed_description>The study require participation 14 day participation le blister heals sooner , recruit 100 subject fluid fill blister heel foot intact break . Some subject ask blister photograph . All subject require blister unroofed ( top layer skin remove physician use sterile instrument ) . All subject receive study product , either test product market product .</detailed_description>
	<mesh_term>Blister</mesh_term>
	<criteria>Male female subject , 18 year age old ; Individuals willing able provide inform consent Female subject child bear potential must negative urine pregnancy test prior application study product ; Females childbearing potential must use medicallyacceptable method birth control least one month prior Visit 1 one list agree continue use method participation study ; Note abstinence approve method birth control . Postmenopausal amenorrheic one year Surgically sterile ( hysterectomy , tubal ligation , oophorectomy ) Use effective method birth control ( e.g . prescription oral contraceptive , contraceptive implant injection , intrauterine device , diaphragm , cervical cap condom spermicide ) Individuals exhibit blister heel determine investigator 72 hour old stage 2 Subject willing blister unroofed ( top layer blister remove ) investigator Subject willing able follow study direction , participate study , return specify visit Pregnant , plan pregnancy actively nurse Exhibits foot blister heel exceed 1125mm2 would otherwise cover hydrogel portion study product Unstable uncontrolled medical condition could require intensive treatment course study Individuals autoimmune disorder include , limited , lupus erythematosus , rheumatoid arthritis , HIV/AIDS Currently participate , within past 30 day participate another clinical study use investigational drug device Employees site , friends/relatives employee would access study information Diabetic , type I type II Treatment type cancer within last 2 year history skin cancer Damaged skin around test sit , include sunburn , extremely deep tan , uneven skin tone , tattoo , scar , excessive hair , numerous freckle , acne , disfiguration test site History clinically determine allergic reaction irritation test product ingredient History know allergy iodine Currently take expect take follow course study : amphetamine , benzodiazepine , cocaine , marijuana , methaqualone , methadone , opiates , propoxyphene , barbiturate , phencyclidine Other severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation investigational product administration may interfere interpretation study result , judgment investigator , would make subject inappropriate entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>